Bristol-Myers Squibb Co  

(Public, OTCMKTS:BMYMP)   Watch this stock  
Find more results for NYSE:BMY-
1,093.50
0.00 (0.00%)
Feb 1 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 993.02 - 1,182.59
Open     -
Vol / Avg. 0.00/0.00
Mkt cap 101.90B
P/E 1,129.98
Div/yield 0.38/0.14
EPS 0.97
Shares 4,178.00
Beta -14.17
Inst. own 29411571%
May 4, 2016
Bristol-Myers Squibb Co Annual Shareholders Meeting (Estimated) - 10:00AM EDT - Add to calendar
Apr 26, 2016
Q1 2016 Bristol-Myers Squibb Co Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Feb 10, 2016
Bristol-Myers Squibb Co at Leerink Partners Global Healthcare Conference
Jan 28, 2016
Q4 2015 Bristol-Myers Squibb Co Earnings Call
Jan 28, 2016
Q4 2015 Bristol-Myers Squibb Co Earnings Release
Jan 12, 2016
Bristol-Myers Squibb Co at JPMorgan Healthcare Conference
  

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -4.39% 9.85%
Operating margin -8.02% 7.61%
EBITD margin - 15.30%
Return on average assets -2.37% 4.98%
Return on average equity -5.39% 10.75%
Employees 25,000 -
CDP Score - 98 B

Address

345 PARK AVE
NEW YORK, NY 10154
United States - Map
+1-212-5464000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

About Company - Wikipedia

Description

Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products across the world. The Company's products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The Company manufactures its products in the United States, Puerto Rico and in six foreign countries. The Company promotes the use of its products directly to healthcare professionals and providers, such as doctors, nurse practitioners, physician assistants, pharmacists, technologists, hospitals, Pharmacy Benefit Managers (PBMs) and Managed Care Organizations (MCOs). It also provides information about the use of its products to consumers in the United States through direct-to-consumer print, radio, television, and digital advertising and promotion. In addition, the Company holds rights to F001287, which is a preclinical, small-molecule IDO1-inhibitor.

Officers and directors

Giovanni Caforio M.D. Chief Executive Officer, Director
Age: 50
Charles A. Bancroft Chief Financial Officer, Executive Vice President
Age: 55
Louis S Schmukler President - Global Manufacturing and Supply
Age: 59
Francis M. Cuss Executive Vice President, Chief Scientific Officer
Age: 60
Sandra Leung Executive Vice President, General Counsel and Corporate Secretary
Age: 54
Trading Activity - Yahoo Finance
Paul von Autenried Senior Vice President - Enterprise Services, Chief Information Officer
Age: 53
Anne Nielsen Senior Vice President, Chief Compliance and Ethics Officer
Age: 54
Joseph C. Caldarella Senior Vice President, Corporate Controller
Age: 59
Trading Activity - Yahoo Finance
Ann Powell Judge Senior Vice President - Global Human Resources
Age: 49
John E. Elicker Senior Vice President - Public Affairs
Age: 55